Strata Critical Medical, Inc. (SRTA) stock
Close on Nov 13, 2026Market cap $487.45MP/E 10.8Yield –
Strata Critical Medical statistics
84 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Mar 2, 2027 (estimated, before the open)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Jun 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 4.34
- 2.19
Enterprise valuationIndustry
- EV / Sales
- 1.82
- 1.45
Share statisticsIndustry
- Shares Change (YoY)
- 8.11%
- 1.45%
- Float
- 70M
- 49M
- Shares Held by Insiders
- 21.0%
- 4.11%
- Shares Held by Institutions
- 63.0%
- 82.2%
Short sellingIndustry
- Short Interest
- 5M
- –
- Short Interest Change
- 0.27%
- -0.27%
- Short % of Float
- 6.51%
- 6.06%
- Short % of Shares Outstanding
- 5.14%
- 4.99%
- Days to Cover
- 4.98
- 4.04
Stock price statisticsIndustry
- 52-Week High
- $6.50
- –
- 52-Week Low
- $3.95
- –
- 20-Day Moving Average
- $5.04
- –
- 50-Day Moving Average
- $5.02
- –
- 200-Day Moving Average
- $5.10
- –
- Average True Range (14)
- $0.30
- –
- Price Change (1 Week)
- -0.90%
- 0.87%
- Price Change (1 Month)
- 27.0%
- -3.17%
- Price Change (3 Months)
- -6.61%
- -12.5%
- Price Change (6 Months)
- 5.56%
- -2.36%
- Price Change (YTD)
- 14.6%
- -20.6%
- Price Change (1 Year)
- 8.04%
- -22.3%
- Price Change (3 Years)
- 55.2%
- 23.2%
- Price Change (5 Years)
- -45.1%
- 9.62%
- Average Volume (10 Days)
- 2M
- –
- Average Volume (20 Days)
- 1M
- –
- Average Volume (90 Days)
- 1M
- –
- Relative Volume
- 0.87
- 0.67
- Relative Strength Index (14)
- 58.0
- 49.8
- Volatility (1 Year)
- 57.1%
- 67.2%
- Beta (5 Years)
- 1.63
- 1.09
MarginsIndustry
- Pretax Margin
- -9.05%
- -4.03%
- EBITDA Margin
- -1.61%
- 0.86%
- FCF Margin
- -18.9%
- 1.25%
Returns on capitalIndustry
- Return on Equity (ROE)
- 16.0%
- -0.47%
- Return on Assets (ROA)
- 13.6%
- -1.75%
- Return on Invested Capital (ROIC)
- -8.80%
- 3.92%
- Return on Capital Employed (ROCE)
- -7.11%
- 3.69%
Financial positionIndustry
- Current Ratio
- 2.64
- 1.41
- Quick Ratio
- 1.45
- 1.00
GrowthIndustry
- Revenue Growth (YoY)
- 66.8%
- 6.71%
- Revenue Growth (3Y CAGR)
- 57.4%
- 5.44%
- Revenue Growth (5Y CAGR)
- 44.6%
- 15.4%
EfficiencyIndustry
- Asset Turnover
- 0.87
- 0.85
- Revenue Per Employee
- $425.92K
- $422.33K
- Profits Per Employee
- $66.92K
- -$11.14K
- Employee Count
- 601
- 1,107
- WACC
- 13.2%
- 9.83%
Income statement (TTM)Industry
- Pretax Income
- -$23.16M
- -$698.68K
Balance sheetIndustry
- Net Cash (Debt)
- $22.75M
- -$2.52M
- Net Cash Per Share
- $0.26
- -$0.31
- Equity (Book Value)
- $279.32M
- $74.92M
- Book Value Per Share
- $3.16
- $3.18
- Tangible Book Value
- $112.36M
- $4.98M
- Working Capital
- $75.23M
- $11.37M
Cash flow (TTM)Industry
- Capital Expenditures
- -$12.42M
- -$21.59M
- FCF Per Share
- -$0.55
- $0.90
Dividends and yieldsIndustry
- Earnings Yield
- 8.25%
- 1.06%
- FCF Yield
- -9.94%
- 3.45%
Taxes and interestIndustry
- Income Tax
- $0
- $2.50M
Scores and fair valueIndustry
- Graham Number
- $6.02
- $25.66
- Graham Upside
- 9.24%
- -39.6%
- Altman Z-Score
- 5.67
- 1.56
- Piotroski F-Score
- 5
- 4
- Beneish M-Score
- 0.05
- -1.51
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | SRTA | S&P 500 | Difference | SRTA per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +23.8% | -3.0% | +26.9 pts | ||
| 3 months | -7.7% | -2.8% | −4.9 pts | ||
| Year to date | +14.6% | +11.5% | +3.1 pts | ||
| 1 year | +12.7% | +13.5% | −0.8 pts | ||
| 3 years | +68.0% | +77.7% | −9.7 pts | +18.9% | +21.1% |
| 5 years | -45.1% | +72.6% | −117.7 pts | -11.3% | +11.5% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
5M SRTA shares were sold short on Oct 30, 2026, up 0.3% from the previous report, or 6.51% of the shares available to trade. At recent volumes it would take 5.0 days to buy them back. Over the last 20 sessions, 34.9% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 4,550,210 | +0.3% | 913,746 | 5.0 |
| Oct 15, 2026 | 4,538,023 | +4.8% | 907,656 | 5.0 |
| Sep 30, 2026 | 4,331,692 | -0.6% | 713,311 | 6.1 |
| Sep 15, 2026 | 4,358,719 | -3.7% | 844,750 | 5.2 |
| Aug 31, 2026 | 4,525,352 | +7.9% | 820,057 | 5.5 |
| Aug 14, 2026 | 4,194,992 | -0.2% | 1,290,425 | 3.3 |
| Jul 31, 2026 | 4,201,679 | -2.9% | 971,950 | 4.3 |
| Jul 15, 2026 | 4,327,351 | +6.2% | 963,671 | 4.5 |
| Jun 30, 2026 | 4,075,056 | -47.9% | 1,622,698 | 2.5 |
| Jun 15, 2026 | 7,824,961 | +56.8% | 1,087,102 | 7.2 |
| May 29, 2026 | 4,991,225 | -27.4% | 1,043,171 | 4.8 |
| May 15, 2026 | 6,877,454 | +7.5% | 1,156,568 | 6.0 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?